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Summary
 
This report investigates the role of OX40 ligand (OX40L) and its receptor, OX40, expressed
on activated B and T cells, respectively, in promoting the differentiation of T helper type 2
(Th2) CD4 T cells. These molecules are expressed in vivo
 
 
 
by day 2 after priming with T cell–
dependent antigens. Their expression coincides with the appearance of immunoglobulin (Ig)G
switch transcripts and mRNA for interleukin (IL)-4 and interferon (IFN)-
 
g
 
, suggesting that
this molecular interaction plays a role in early cognate interactions between B and T cells. In
vitro, we report that costimulation of naive, CD62L
 
high
 
 CD4 T cells through OX40 promotes
IL-4 expression and upregulates mRNA for the chemokine receptor, blr-1, whose ligand is ex-
pressed in B follicles and attracts lymphocytes to this location. Furthermore, T cell stimulation
through OX40 inhibits IFN-
 
g
 
 expression in both CD8 T cells and IL-12–stimulated CD4 T
cells. Although this signal initiates IL-4 expression, IL-4 itself is strongly synergistic. Our data
suggest that OX40L on antigen-activated B cells instructs naive T cells to differentiate into Th2
cells and migrate into B follicles, where T cell–dependent germinal centers develop.
Key words: Th1–Th2 differentiation • OX40/OX40 ligand • cytokine • T cell priming • 
cognate B cell–T cell interaction
 
T
 
he mammalian immune system has evolved to deal
with two principal groups of pathogens: extracellular
organisms, which are opsonized by antibody and complement
and are killed when ingested by phagocytes; and intracellu-
lar bacterial organisms like 
 
mycobacteria
 
, which escape the
normal intracellular killing mechanisms and replicate inside
host cells. T cells play a crucial role in orchestrating host
defences against both types of pathogen. In mice and hu-
mans, two distinct patterns of Th cell have been described.
Th1 cells, by virtue of their capacity to secrete IFN-
 
g
 
, play
a crucial role in eliminating intracellular bacteria in mice
and humans (1); Th2 CD4 T cells are more effective help-
ers for antibody responses.
Recent experiments suggest that commitment of CD4 T
cells to Th1 or Th2 subsets occurs at or shortly after T cell
priming on dendritic cells (DC)
 
1
 
 (2). It is well established
that IL-12 plays the key role in directing Th1 cell CD4 dif-
ferentiation (3), and this cytokine can be secreted by acti-
vated DC (4, 5). The factors that initiate Th2 CD4 differ-
entiation are less well understood. IL-4 promotes Th2
CD4 differentiation and inhibits Th1 cells by downregulat-
ing the 
 
b
 
 chain of the IL-12 receptor (6). It has been sug-
gested that NK1.1 cells (7) are the initial sources of IL-4,
but NK1.1-deficient mice make normal Th2 responses (8).
Alternatively, there is evidence that B cells evoke Th2
differentiation (9, 10). The appearance of IgG switch tran-
scripts coincident with the appearance of mRNA for cy-
tokines during immune responses to T cell–dependent an-
tigens supports the notion that B cells interacting with T
cells might play a role in initiating IL-4 secretion (2).
It has been reported previously that the expression of
OX40 on T cells in the T zone is maximal 3 d after prim-
ing (11). In this paper, we confirm that the B cell activation
antigen, OX40 ligand (OX40L), and the T cell activation
antigen, OX40, are expressed by day 2 at the time of T cell
priming in vivo. We report that costimulation of naive
CD62L
 
high
 
 T cells through OX40 promotes IL-4 expres-
sion and upregulates the chemokine receptor, CXCR5
 
1
 
Abbreviations used in this paper:
 
 DC, dendritic cell(s); h, human; L, ligand;
m, murine; MMTV, Swiss-type mouse mammary tumor virus; NP-C
 
g
 
G,
(4-hydroxy-3-nitrophenyl) acetyl–chicken 
 
g
 
 globulin; RT, reverse tran-
scription.
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(blr-1), whose ligand is expressed in B follicles (12). Al-
though OX40L initiates IL-4 responses, subsequent differ-
entiation is IL-4 dependent. In addition, IL-4 inhibits IFN-
 
g
 
expression in both CD8- and IL-12–stimulated CD4 T
cells. Our data suggests a mechanism whereby antigen-acti-
vated B cells promote the differentiation of Th2 cells and
their recruitment to B follicles, where T cell–dependent
germinal centers develop.
 
Materials and Methods
 
Construction of Murine OX40L Transfectant.
 
Construction and
expression of stable transfectants expressing murine (m)OX40L
protein were carried out as follows.
The primers used to amplify mOX40L were 5
 
9
 
 (TATATA-
GAGCTCACCATGGAAGGGGAAGGGGTTCAACCCC) and
3
 
9
 
 (ATATATAAGCTTACTTACCTCACAGTGGTACTTGG-
TTCACAGT).
Reverse transcription (RT)-PCR
 
 
 
using immunized mouse
spleen cDNA as a template
 
 
 
was used to amplify cDNA encoding
mOX40L. The PCR product was subcloned into an expression
plasmid containing prokaryotic (Ampicillin) and eukaryotic (histi-
dinol) selection markers, and promoters and enhancers for murine
B cells and plasma cells. The plasmid has been described else-
where (13).
 
Construction of mOX40–Human 
 
g
 
1.
 
The primers used to am-
plify mOX40 were 5
 
9
 
 (TATATAGAGCTCACCATGGCATG-
TATGTGTGGGTTCAGCAGCC) and 3
 
9
 
 (ATATATAAGCT-
TACTTACCCTCAGGAGTCACCAAGGTGGG).
Chimeric Ig molecules expressing the extracellular portions of
the mouse OX40 gene (14) and the human IgG1 constant do-
mains were created as follows. External primers encoding the 5
 
9
 
portion and the 3
 
9
 
 portion of mOX40 were used to amplify the
extracellular portion of mOX40 (from mouse spleen cDNA).
Each primer contained appropriate restriction sites for subcloning
into the human IgG1 expression vector (13), together with a 3
 
9
 
splice donor site within the 3
 
9
 
 primer to correctly splice to the
human (h)
 
g
 
1 exons.
 
Transfection of Plasmids into J558L.
 
Plasmids containing the cor-
rect insert were linearized and electroporated into the mammalian
plasmacytoma cell line, J558L, and selected in 10 mM Histidinol
(Sigma Chemical Co., St. Louis, MO) for the OX40L transfec-
tant, or mycophenolic acid and Xanthine (Sigma Chemical Co.)
for mOX40-h
 
g
 
1 (13). The fusion proteins were detected by he-
magglutination of SRBC coated with an antibody to human IgG.
Strongly secreting clones were grown, and supernatants were pu-
rified over protein A as described previously (15).
mOX40L transfectants that stained appropriately with
mOX40-h
 
g
 
1 but not an irrelevant fusion protein were selected
and used for T cell stimulation studies (data not shown).
 
Preparation of CD4CD62L
 
high
 
 and CD8CD62L
 
high
 
 T Cells.
 
6–12-
wk-old female BALB/c or C57BL/6 mice were killed, and their
spleen and LNs were removed. Cell suspensions were made by
crushing the tissues between gauze. After separation with Ficoll-
paque (Amersham Pharmacia Biotech, Herts, UK), the cell sus-
pensions were pooled and incubated with FITC-conjugated anti-
CD4 or anti-CD8 antibody (Southern Biotechnology Associates,
Inc., Birmingham, AL) at 20 
 
m
 
l/10
 
8
 
 cells, for 15 min at 4
 
8
 
C.
FITC-stained single cells were positively selected using MACS
 
Ò
 
anti-FITC (isomer 1) Multisort kit (Miltenyi Biotec Ltd., Surrey,
UK) and a miniMACS
 
Ò
 
 separation unit according to the manu-
facturer’s protocol. The resulting positive fraction was further
separated according to expression of CD62L using MACs
 
Ò
 
 anti–
mouse CD62L microbeads (Miltenyi Biotec Ltd.), again accord-
ing to the manufacturer’s protocol. The resulting population was
typically 
 
.
 
95% positive for CD4 or CD8 and CD62L as deter-
mined by flow cytometry using a FACScan
 
Ò
 
 (Becton Dickinson,
Mountain View, CA).
 
T Cell Stimulation, Cytokines, and Antibodies.
 
For cell culture,
J558L and the mOX40L and hCD27L transfectants were fixed in
1% formaldehyde for 45 min at 4
 
8
 
C and washed thoroughly. Via-
bility after fixation was undetectable, but OX40L transfectants
could still be stained with the mOX40-h
 
g
 
1 fusion protein. RT-
PCR did not give a 
 
b
 
-actin signal from fixed cells, and only cell
debris remained after 3 d in culture (data not shown).
24-well plates (GIBCO BRL, Paisley, UK) were coated over-
night with anti-CD3 antibody (10 
 
m
 
g/ml; PharMingen, San Di-
ego, CA) at 4
 
8
 
C. CD4
 
1
 
CD62L
 
1
 
, CD4
 
1
 
CD62L
 
2
 
 enriched, or
CD8
 
1
 
 CD62L
 
1
 
 T cells (1–2 
 
3
 
 10
 
6
 
 cells/well) were cultured ei-
ther alone or with the addition of 5 
 
3
 
 10
 
5
 
 cells per well of fixed
OX40L transfectants or the fixed parental cell line (J558L). The
cultures were incubated with soluble anti-CD28 antibody (10%
final concentration from a supernatant of a hamster anti–mouse CD28
(clone 37.51; a gift from Dr. Jim Allison, University of California,
Berkeley, CA) in RPMI 1640 medium containing 
 
l
 
-glutamine
(GIBCO BRL) supplemented with 10 U/ml penicillin/100 
 
m
 
g/ml
streptomycin (GIBCO BRL), ciprofloxacin (10 
 
m
 
g/ml; Sigma
Chemical Co.), and 10% FCS (GIBCO BRL) at 37
 
8
 
C with 5% CO
 
2
 
.
For blocking experiments, purified rat anti–mouse IL-4 anti-
body (11B11) or anti–mouse IFN-
 
g
 
 antibody (XMG1.2) was
added to the cultures at a concentration of 50 
 
m
 
g/ml. Recombi-
nant mouse IL-12 (R&D Systems, Abingdon, UK) was used at 50
ng/ml, which in our hands gave optimal induction of IFN-
 
g
 
.
 
Restimulation of T Cells for FACS
 
Ò
 
 Analysis for CD40L, IL-4,
and IFN-
 
g
 
.
 
At the required time points, the cultures were har-
vested and washed thoroughly to remove antibodies. The cul-
tures were restimulated with anti-CD3 mAb for 4 h at 37
 
8
 
C as
described above in the presence of GolgiStop
 
Ô
 
 according to the
manufacturer’s protocol (Cytofix/Cytoperm Plus
 
Ô
 
 cytostain kit;
PharMingen). Without GolgiStop
 
Ô
 
, intracellular cytokine stain-
ing was not detectable. Cells incubated with GolgiStop
 
Ô
 
 but not
restimulated gave a similar pattern of staining to restimulated cells,
but the intensity was less (data not shown).
After restimulation, the cells were fixed and permeabilized ac-
cording to the manufacturer’s protocol for the cytostain kit. The
cells were stained optimally with anti-CD4 FITC or anti-CD8 FITC
mAb (Southern Biotechnology Associates, Inc.), biotinylated
anti–IL-4, biotinylated anti–IFN-
 
g
 
 (PharMingen), and biotiny-
lated MR1 anti-CD40L antibody (a gift of Dr. Randy Noelle, Dart-
mouth Medical School, Lebanon, NH). After washing, the cells
were stained in a second step with neutralite avidin PE (Southern
Biotechnology Associates, Inc.) at 1:200 final concentration. For
each sample, 10
 
4
 
 live gated cells were analyzed using a FACScan
 
Ò
 
(Becton Dickinson).
 
Semiquantitative RT-PCR.
 
To obtain cell samples for cDNA
preparation, the above culture conditions were duplicated on rat
anti–mouse CD3 (10 
 
m
 
g/ml)–coated 96-well plates. CD4
 
1
 
CD62L
 
1
 
 cells were plated in triplicate at 10
 
5
 
 cells/well with the
addition of 3 
 
3
 
 10
 
4
 
 cells/well of the fixed transfected cell line.
Cell cultures were harvested without restimulation at time 0, and
after 24, 48, and 72 h. The cells were washed in PBS, and the dry
pellet was frozen at 
 
2
 
70
 
8
 
C before cDNA preparation. cDNA
was also made from the J558L cell line and transfectants. Living
cells gave a strong 
 
b
 
-actin signal, but no signal was detected for
IL-4, IFN-
 
g
 
, or blr-1. Fixed cell lines did not give a 
 
b
 
-actin signal. 
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For in vivo
 
 
 
studies, mice were killed by CO
 
2
 
 asphyxiation at
different time points after immunization. Draining popliteal LNs
were removed and put on aluminium foil in a defined orienta-
tion, embedded in OCT compound (Miles Inc., Elkhart, IN),
and frozen by sequential dipping in liquid N
 
2
 
. Tissues were stored
in sealed polythene bags at –70
 
°
 
C until use. 5-
 
m
 
m cryostat sec-
tions of the tissue were mounted on four-spot glass slides for im-
munohistology. After cutting the first eight sections, which were
used for immunohistology, three 24-
 
m
 
m sections of LN were cut,
placed in a polypropylene microfuge tube, and stored at –70
 
°
 
C
for mRNA extraction. cDNA samples were prepared from tissue
sections from popliteal LNs taken from mice at different time
points during immune responses to Swiss-type mouse mammary
tumor virus (MMTV) or (4-hydroxy-3-nitrophenyl) acetyl–
chicken 
 
g
 
-globulin (NP-C
 
g
 
G) as described (2).
cDNA prepared from the cells or tissue sections was diluted to
a final volume of 100 
 
m
 
l. The PCR 
 
b
 
-actin signal was used to
correct for differences in the amount of starting cDNA from each
sample. The specific primers were as follows: 
 
b
 
-actin (Stratagene,
Cambridge, UK), 5
 
9 
 
(AGCGGGAAATCGTGCGTG) and 5
 
9
 
(CAGGGTACATGGTGGTGCC); IL-4 (16), 5
 
9 
 
(GAATGT-
ACCAGGAGCCATATC) and 5
 
9 
 
(CTCAGTACTACGAGTA-
ATCCA); IFN-
 
g
 
 (16), 5
 
9 
 
(AACGCTACACACTGCATCTTGG)
and 5
 
9 
 
(GACTTCAAAGAGTCTGAGG); blr-1 (17), 5
 
9 
 
(TTC-
CTGTTCCACCTCGCAGTAGC) and 3
 
9 
 
(CCATCCCATC-
ACAAGCATCGG); mOX40, 5
 
9 
 
(TGTATGTGTGGGTTCA-
GCAGCC) and 5
 
9 
 
(CCCTCAGGAGTCACCAAGGTGGG);
mOX40L, 5
 
9 
 
(ATGGAAGGGGAAGGGGTTCAACC) and 5
 
9
 
(TCACAGTGGTACTTGGTTCACAG).
Buffers were used as supplied with the enzymes, plus 1 
 
m
 
M of
each primer, 200 
 
mM of each dNTP, and 1.5 mM MgCl2 for
b-actin, IL-4, and IFN-g cDNAs, or 2.0 mM MgCl2 for blr-1
cDNAs. cDNAs were amplified using 0.1 ml AmpliTaq Gold (Per-
kin-Elmer, Langen, Germany). PCR was performed with 2 ml
cDNA template in a 20 ml vol, and the reaction mix was overlaid
with one drop of mineral oil (Sigma Chemical Co.). The PCRs
were performed in 0.2 ml polypropylene plates in a Touch Down
thermal cycler (Hybaid Ltd., Ashford, Middlesex, UK). Cycling
was done with an initial denaturation step of 9 min, followed by
30 s at 948C, 30 s at annealing temperature (608C for b-actin,
558C for blr-1, and 508C for cytokine mRNA), and 2 min plus 2 s
for every cycle at 728C. Cycle numbers were 22 for b-actin, 30
for IL-4 and IFN-g mRNA, and 35 for blr-1 mRNA. After a fi-
nal elongation step of 15 min at 728C, the PCR product was sep-
arated on a 1.5% agarose gel containing ethidium bromide, and
photographed.
For semiquantitative PCR of OX40 and OX40L mRNA,
z10 fewer cycles than were required to detect PCR product us-
ing ethidium bromide gels were done to quantitate OX40 and
OX40L cDNAs by PCR Southern blot or dot blot analysis. For
each set of primers, three different numbers of PCR cycles were
performed to ensure that amplification was logarithmic and that
the conditions were not saturating. The PCR product was sepa-
rated on a 1.5% agarose gel and transferred onto prewetted Hy-
bond-N1 membrane (Amersham International, Little Chalfont,
UK) by capillary transfer under alkaline conditions. The mem-
brane was hybridized with a 32P-labeled purified PCR product
used as a probe and imaged using a PhosphorImager (Molecular
Dynamics Ltd., Buckinghamshire, UK).
Using ImageQuant software (Molecular Dynamics Ltd.), a grid
was laid over PCR bands, with individual fields covering the cen-
tral 50% of a band. The signal in each field was calculated, and
these figures were transferred to spreadsheet software to sort the
randomized files to the correct order. The average of the three
PCRs with different cycle number for each gene was taken and
divided by the average of the three corresponding b-actin PCRs.
These values represent the relative amount of mRNA for each
gene per cell. This value was multiplied by the size of the section
area (determined by microscopy on adjacent sections to those
taken for cDNA using the point counting technique [18]) to give
mRNA amount per section.
Results
In Vivo, The Timing of Expression of OX40 and OX40L
Correlates with Priming of B and T Cells. During immune re-
sponses to the nominal haptenated protein antigen NP-CgG
and the infectious viral superantigen MMTV (2), T cell prim-
ing occurs around day 3. The predominant cytokine associated
with MMTV is IFN-g, whereas IL-4 is secreted in response
to NP-CgG. Antigen presentation of the superantigen by
MMTV on B cells is associated with T cell–driven prolifer-
ation of large numbers of B cells. The response to NP-CgG is
of lower magnitude, with activation of antigen-specific B
cells. We examined mRNA expression of OX40L and OX40
during these two immune responses (see Fig. 1, A–D).
Figure 1. Induction of OX40 and OX40L after im-
munization. Time course of induction of mRNA for
OX40 and OX40L in popliteal LNs in mice after im-
munization with NP-CgG (plus killed Bordetella pertussis
5 3 108) or MMTV. Symbols show the amount of
mRNA for OX40L (A and B) and OX40 mRNA (C
and D) per LN section by semiquantitative PCR. Symbols,
Results for individual mice; solid lines, median values.300 OX40 Ligand Upregulates Blr-1 and IL-4 in Naive CD4 T Cells
During immune responses to MMTV, which potently
activates B cells (19), OX40L is strongly induced. There is
a 10-fold increase in mRNA expression between days 2
and 3, and by day 5, the peak of the B cell response, there
is a further 5-fold increase in mRNA (Fig. 1 B). OX40
mRNA is also upregulated about fivefold by day 2 of the
immune response (Fig. 1 D). The response to the nominal
protein antigen NP-CgG is less marked but exhibits similar
kinetics. Increased OX40 and OX40L mRNA is in evi-
dence by day 2 and peaks on day 3 of the immune re-
sponse, coinciding with the early cognate interaction among
B cells, T cells, and DC. mRNA levels for OX40 and
OX40L remain elevated above baseline levels for several
weeks in both immune responses. The predominant site of
B–T interaction is within the light zone of germinal centers
at these late time points. In summary, these results indicate
that OX40 and its ligand are expressed from the time of B
and T cell priming in vivo, and could therefore play a role
in directing subsequent T and B cell differentiation.
Stimulation of Naive CD4 T Cells (CD62high) through CD3
and CD28 Is Insufficient to Induce Expression of Intracytoplasmic
IL-4 or IFN-g. Previous evidence has suggested that cross-
linking of OX40L on B cells by T cell OX40 delivers a B cell
differentiation signal (20). To dissect the effects of OX40L
on signaling through T cell OX40, we developed an in vitro
model to study naive CD4 T cell activation and differentiation.
CD41CD62Lhigh T cells that were .95% pure were
compared with total or CD41CD62Llow T cells for their
capacity to upregulate the expression of intracytoplasmic
IL-4 and IFN-g after activation through CD3 and CD28.
In our system, CD4 T cells are activated for short periods
(up to 3 d). This time frame was chosen to mimic as closely
as possible the in vivo situation (2).
Before staining for intracytoplasmic IL-4 and IFN-g, T
cells were restimulated by immobilized mAb to CD3 for 4 h
in the presence of GolgiStopÔ, which causes newly syn-
thesized proteins to accumulate within the Golgi compart-
ment. Without GolgiStopÔ, cytokine expression could not
be detected. If GolgiStopÔ was added to cultures without
restimulating with anti-CD3 mAb, a similar pattern of cy-
tokine expression was observed, but levels were much lower
(data not shown).
Results of a typical experiment are shown in Fig. 2. In
the absence of IL-12 or other costimuli besides CD3 and
CD28, a substantial fraction of CD62Llow-enriched CD4 T
cells are induced to express IL-4, but few express IFN-g
(Fig. 2, A and B). In contrast, IFN-g was strongly ex-
pressed by z30% of naive CD81CD62Lhigh cells 72 h after
activation with the same CD3 and CD28 stimulus (Fig. 2
D). Almost no CD8 T cells expressed detectable levels of
IL-4 (Fig. 2 C).
Naive CD41CD62Lhigh T cells activated in parallel failed
to express either IL-4 or IFN-g (Fig. 2, E and F). This was
not because of lack of activation of these T cells, as they
were stimulated to divide and upregulate expression of
CD40L (see Fig. 3 A).
OX40L Induces IL-4 but not IFN-g Expression in Naive
CD4 CD62Lhigh T Cells. The above data indicated that
naive CD4 T cells need signals other than those through
their TCR and CD28 to upregulate expression of IL-4 or
IFN-g. IL-12, which can be produced by activated DC (4,
5), has been shown to be the principal cytokine involved in
differentiation of Th1 CD4 T cells. Because we had ob-
served that OX40L was upregulated at or about the time of
T cell priming, we investigated whether this molecule
could increase expression of IL-4 or IFN-g within the 3-d
time frame of priming of naive CD4 T cells in vivo. As can
be seen from Fig. 3 A, OX40L transfectants but not the pa-
rental cell line, J558L, induced substantial expression of IL-4
but not IFN-g by day 3. The effect of the OX40L transfec-
tant could consistently be partially abrogated (z30%) by
preincubating the transfectant cell line with OX40-hg1 (10
mg/ml) before the addition of T cells. Because the T cells
are in contact with the OX40L transfectant for several days,
we found it impossible to obtain complete inhibition of the
OX40L effect with the Ig fusion protein (data not shown).
The effects of OX40L cannot simply be attributable to better
activation, as levels of CD40L induced on CD4 T cells were
comparable. CD4 T cells enriched for activated CD62Llow
cells expressed high levels of IL-4, irrespective of the co-
stimulus (data not shown). A time course of induction of
expression of IL-4 by OX40L showed no expression until
day 2 (Fig. 3 B), a result consistent with the induction of
IL-4 in vivo (2). These experiments were performed in
both Balb/c and C57Bl/6 inbred strains of mice. The yield
of CD41CD62Lhigh cells was consistently greater from
Balb/c mice (z30%), and these cells survived much better
in culture. In both strains of mice, OX40L induced expres-
Figure 2. Intracellular staining for IL-4 and IFN-g on activated sub-
populations of T cells. Purified subpopulations of CD4 and CD8 T cells,
which had been activated for 3 d with immobilized mAb to CD3 and sol-
uble mAb to CD28, were restimulated through CD3 for 4 h in the pres-
ence of GolgiStopÔ to cause accumulation of intracellular cytokines be-
fore staining on the FACsÒ. Histograms show the proportion of cells
positive compared with a negative control mAb: CD4+CD62Llow T cells
enriched for activated and memory T cells (A) IL-4 and (B) IFN-g; CD8+
CD62Lhigh naive T cells (C) IL-4 and (D) IFN-g; and CD4+CD62Lhi na-
ive T cells (E) IL-4 and (F) IFN-g. lo, Low; hi, high.301 Flynn et al.
sion of intracellular IL-4, although the proportion of CD4
T cells expressing IL-4 was less in the C57Bl/6 strain
(z50% of that seen in Balb/c mice; three experiments).
Data is shown for Balb/c mice, which were used in most
experiments because of the increased yield and better sur-
vival in culture of purified T cells.
Induction of IL-4 in CD4 T Cells by OX40L Is Dependent
on IL-4 and Blocked by Neutralizing Anti–IL-4 Antibodies.
The above experiments indicated that OX40L upregulated
the expression of IL-4 in naive CD4 T cells. It is well es-
tablished that IL-4 itself promotes CD4 Th2 differentia-
tion. To test whether OX40L was dependent on IL-4 for
its effect, T cells were stimulated for 3 d in the presence of
neutralizing IL-4 and IFN-g mAb. Cells were washed ex-
tensively before restimulation to remove excess mAb that
could interfere with the intracellular staining process. As
can be seen from Fig. 4 A, anti–IL-4 mAb blocked the in-
duction of intracytoplasmic IL-4 in CD4 T cells. mAb to
IFN-g partially blocked IL-4 expression, but this effect was
much less marked.
IL-12–induced Th1 Differentiation of CD4 T Cells Is Sub-
stantially Blocked by OX40L. A substantial proportion of
Figure 3. Induction of IL-4 expression by OX40L. CD62Lhigh CD8 and CD4 T cells were activated through CD3 and CD28 for 3 d in the presence
of a fixed OX40L transfectant or the control parental cell line. Cells were restimulated through CD3 for 4 h in the presence of GolgiStopÔ and stained
for intracellular expression. (A) Staining with a control mAb (striped bars), anti-CD40L (black bars), anti–IL-4 (white bars), and anti–IFN-g (stippled bars), on
purified CD4 or CD8 CD62Lhigh T cells. The above data are representative of at least 10 different experiments. (B) Timing of induction of IL-4 expres-
sion in naive T cells by OX40L. Cells were stimulated as above. Data are representative of two experiments. hi, High.
Figure 4. (A) Dependence of OX40L effect on IL-4 and IFN-g secre-
tion. Purified CD4+CD62Lhigh T cells were stimulated as described in the
legend to Fig. 3 in the presence or absence of neutralizing mAbs to IL-4
and IFN-g at a final concentration of 50 mg/ml. Before restimulation,
cells were washed three times in medium to remove excess cytokine anti-
body. This was done to prevent interference with subsequent staining for
intracellular cytokines. A shows the percentage of IL-4– or IFN-g–posi-
tive CD4+ T cells when T cells were stimulated alone, with J558L, or
with OX40L-fixed transfectants. Data shown are representative of six ex-
periments in Balb/c mice. C57Bl/6 mice gave qualitatively similar results,
but the degree of IL-4 expression was less (three experiments). Striped
bars, Control; white bars, IL-4; stippled bars, IFN-g. (B) Effect of OX40L
on intracellular expression of IFN-g in CD4 and CD8 T cells. CD4 and
CD8 T cells were activated for 3 d as described in the legend to Fig. 2.
To induce IFN-g expression in CD4 T cells, IL-12 was added to cultures
at a final concentration of 50 ng/ml. a, c, e, and g, Effects of OX40L and
blocking cytokine mAbs on IFN-g expression in CD4 T cells. b, d, f, and h,
Effects on CD8 T cells. Results are representative of five separate experi-
ments. hi, High.302 OX40 Ligand Upregulates Blr-1 and IL-4 in Naive CD4 T Cells
naive CD8 (Fig. 2 D) but not CD4 (Fig. 2 F) T cells ex-
presses IFN-g when costimulated with CD3 and CD28
alone. However, if IL-12 is added to cultures, IFN-g is
strongly upregulated within activated CD62Lhigh CD4 T
cells (Fig. 4 B, a). In the presence of IL-12, substantial
numbers (z25%) of activated CD4 cells express IFN-g by
day 3, and this is substantially inhibited in the presence of
OX40L (5%). OX40-hg1 abrogated the effect of OX40L
on IFN-g expression, confirming that the effects were at-
tributable to this molecule (data not shown). The effect of
OX40L on IFN-g expression is inhibited when blocking
IL-4 mAbs are added (Fig. 4 B, e), suggesting that its effects
on CD4 Th1 differentiation are mediated by IL-4. IFN-g
blocking mAbs also inhibit CD4 Th1 differentiation (Fig. 4
B, g), confirming a previous report (6). Qualitatively similar
experimental results were obtained using C57Bl/6 mice,
but the inhibition of IFN-g expression was less marked,
correlating with the lower induction of IL-4.
OX40L also inhibits induction of IFN-g from 45 to 16%
in naive CD8 T cells (Fig. 4 B, g). This effect is resistant to
blocking mAbs to either IL-4 or IFN-g (Fig. 4 B, f and h).
Expression of mRNA for the Chemokine Receptor, Blr-1, Is
Upregulated by OX40L. Differentiation of CD4 T cells is
associated not only with distinct cytokines but also with the
propensity to migrate to different sites. Th1 cells express
adhesion molecules which allow them to migrate to where
endothelium is inflamed (21). In contrast, Th2 cells express
the eotaxin receptor (CCR3), which perhaps allows them
to migrate to sites of allergic responses (22). Another chemo-
kine receptor, blr-1 (CXCR5), is implicated in the migra-
tion of B and T cells into follicles (23) where the ligand is
expressed (12). We examined the expression of mRNA for
this chemokine receptor in parallel with cytokine expres-
sion on CD4 T cells activated with and without OX40L.
Blr-1 was not expressed on naive CD4 T cells, but after
3 d costimulation with OX40L but not the parental line,
J558L, blr-1 mRNA was strongly upregulated (Fig. 5). Ex-
pression of this mRNA was blocked only partially by neu-
tralizing mAb to IL-4.
The expression of mRNA for IFN-g and IL-4 mRNA
paralleled that seen by staining for intracellular cytokines,
even though cells had not been restimulated. This confirms
that restimulation does not alter the pattern of cytokines
expressed. In these experiments, blocking mAb to IL-4 in-
hibits mRNA expression, showing that the effects of OX40L
on IL-4 expression are dependent on IL-4.
Discussion
T and B cell immune responses to protein antigens are
initiated in the T zone (24, 25). Some B cells differentiate
locally to plasma cells, while others are induced to migrate
into B follicles and form germinal centers with the help of
antigen-specific T cells. Recent data have shown that T
cell cytokine commitment starts z2 d after immunization:
soluble protein antigens evoke predominantly Th2 CD4 T
cell responses, whereas responses to viral antigens are more
complex and show a mixture of Th1 and Th2 cytokines
(2). It is crucial that CD4 T cells make the appropriate cy-
tokine response, as resistance to intracellular bacterial infec-
tions like mycobacteria is dependent on IFN-g production.
How do CD4 T cells decide? We present evidence in this
paper that effector cells play an important role in the deci-
sion-making process by interacting with CD4 T cells at the
time of T cell priming.
It has been reported previously that cross-linking of Ig
receptors or CD40 ligation of B cells upregulates the ex-
pression of OX40L (20), and there is experimental evi-
dence that blocking this interaction abrogates B cell differ-
entiation in the T zone in vivo (11). We have found that
OX40L and its receptor, OX40, are upregulated between
days 2 and 3, when T and B cells are primed in vivo. To
study whether OX40L induces differentiation of naive T
cells, an in vitro system was developed. In this model, sig-
nals through CD28 and the TCR were insufficient to in-
duce either IL-4 or IFN-g expression during the first 3 d of
priming of naive CD4 cells, which nevertheless proliferated
(data not shown) and expressed CD40L. This time frame
was chosen because it reflected the commitment of CD4 T
cells to IL-4 or IFN-g production in vivo. The addition of
fixed OX40L but not control transfectants induced IL-4
expression that was detectable by day 2 and strongly ex-
pressed by day 3. This temporal expression coincided with
that seen in vivo. This effect was inhibited if IL-4 was neu-
tralized during the priming process, suggesting that OX40L
initiates Th2 differentiation but IL-4 plays the dominant
role thereafter. In addition, OX40L upregulated the ex-
pression of blr-1, a chemokine receptor implicated in the
migration of T and B cells into follicles (12, 23).
In contrast to naive CD4 T cells, naive CD8 T cells pro-
duced IFN-g when costimulated through CD28 and TCR
alone. IFN-g expression in naive CD4 T cells could be
readily induced by IL-12, but expression was substantially
inhibited by OX40L. This effect was mediated in part by
IL-4, as neutralizing IL-4 antibodies mitigated this effect.
A Model for Th2 Decision-making in Naive CD4 T Cells.
There is increasing evidence that the type of antigen or the
way in which it is presented to the immune system can reg-
ulate subsequent cytokine responses by CD4 T cells (2, 5).
It has been shown previously that antigen dosage can regu-
late commitment to Th1 or Th2 CD4 pathways in vitro
Figure 5. OX40L induces IL-4
and blr-1 mRNA in naive CD4
T cells. The ethidium bromide
gel shows semiquantitative RT-
PCR for IL-4, IFN-g, and blr-1
in cell samples of activated CD4
CD62Lhigh T cells at the times
indicated after culture. Amounts
of mRNA were adjusted to give
comparable b-actin signals. T cells
had been stimulated in the presence of fixed parental cell line J558L or
OX40L transfectant with and without mAb to IL-4 and IFN-g. RT-PCR
of the fixed cell lines did not yield cDNA that could be amplified. Results
are representative of three experiments. Nil, no blocking mAb added.303 Flynn et al.
(26). However, the cytokine IL-12 must play the crucial
role in Th1 differentiation, as IL-12–deficient mice and
humans cannot mount effective IFN-g responses to intra-
cellular pathogens. IL-6 has been proposed be the Th2 cy-
tokine equivalent of IL-12, as it is able to initiate IL-4 se-
cretion in CD4 T cells (27). However, the phenotype of
IL-6–deficient mice, which make Th2 responses, suggests
that this cannot be an exclusive mechanism (28).
Our data are consistent with a model where CD4 T cells
are not committed initially to make either IL-4 or IFN-g
when they are activated by signals through CD28 and the
TCR on DC. Instead, their differentiation is guided by
secondary signals from the effector cell with which they in-
teract. We show here that OX40L is a sufficient accessory
signal to initiate early Th2 differentiation in naive CD4 T
cells. We propose that antigen-activated B cells, which are
programmed to migrate to T cell areas (29), engage CD4 T
cells around the time of their priming. Signaling through
CD40 or surface Ig on B cells upregulates the expression of
OX40L, which engages OX40 on the activated cognate
CD4 T cell. This signal sets in motion a self-reinforcing IL-4
loop in primed CD4 T cells that further promotes Th2 dif-
ferentiation. IL-12 can be produced by DC (4, 5), and a re-
cent report suggests that human DC can express OX40L
(30). By inducing IL-12 or OX40L, respectively, antigens
might effectively evoke Th1- and Th2-promoting DC.
OX40L Induces Naive T Cells to Express Blr-1, A Chemokine
Receptor Whose Ligand Is Expressed in B Follicles. Th1 differ-
entiation is associated with the upregulation of chemokine
receptors CXCR3 and CCR5 (31) and the expression of
adhesion molecules that allow them to migrate into in-
flamed tissue (21). In contrast, Th2 cells express the eotaxin
receptor, CCR3, which allows them to migrate to allergic
sites (22). Some T cells express CXCR5 (blr-1), a chemo-
kine receptor whose ligand is expressed in follicles. Our data
show that OX40L upregulates blr-1, and therefore directs
not only Th2 differentiation but also migration of T cells
into follicles to help B cells. Although blocking OX40 in-
teractions in vivo does not abrogate germinal center devel-
opment (11), this probably reflects redundancy within the
CD40 family of receptor ligands. We have found that
CD27L, which can be expressed on activated B cells (32)
and whose receptor is expressed on T cells, induces similar
effects on naive CD4 T cells (our unpublished observations).
Production of IFN-g by Activated Naive CD8 T Cells Helps
CD4 T Cells Make Th1 Responses. IL-12 and IFN-g play
a crucial role in responses to intracellular bacterial antigens.
Although the immune system may have evolved to recog-
nize specific intracellular pathogens (5), it seems likely that
there is some default mechanism for recognizing such in-
fections. Differential processing of antigen by DC might
determine whether they produced IL-12.
Alternatively, the experiments described here raise a sec-
ond possibility. During responses to extracellular antigens,
CD8 T cells are not generally primed as antigen is pre-
sented in association with MHC class II molecules. This is
not the case with intracellular infections where both CD8
and CD4 T cells are activated by antigens presented on
MHC class I and II molecules, respectively. Most CD8 re-
sponses require Th1 CD4 help (IL-2), but unlike B cells,
CD8 lymphocytes do not engage cognately with CD4 T
cells. The default expression of IFN-g (which promotes
Th1 differentiation [6]) by naive CD8 T cells during T cell
priming perhaps offers a mechanism for instructing naive
CD4 T cells to remain responsive to IL-12 (6), and DC to
produce IL-12 (33). This idea is supported by recent data
suggesting that CD8 T cells play an important role in the
generation of protective Th1 CD4 responses (34), and in
particular IFN-g produced by these CD8 T cells (35).
Most Responses Require a Mixture of Th1 and Th2 CD T
Cells. Most intracellular infections, particularly viruses,
require a combination of high affinity antibody and cyto-
toxic CD8 T cells for the best protective immunity. We
show here that OX40L will inhibit Th1 differentiation
promoted by IL-12. This suggests a mechanism whereby B
cells can efficiently evoke Th2 cytokines from CD4 T cells
in an environment where IL-12 is inducing IFN-g. This is
demonstrated in the response to MMTV, where IL-4 pro-
duction after IFN-g is associated with the development of
germinal centers (2) and the production of neutralizing an-
tiviral envelope antibodies (19).
The authors would like to thank Ian MacLennan, Matt Cook, Lucy Walker, and Carola Garcia for their
comments on the manuscript.
This work was supported by grants from The Royal Society and from the Wellcome Trust to P. Lane. S.
Flynn is supported by a Medical Research Council Ph.D. studentship.
Address correspondence to Peter Lane, Department of Immunology, Birmingham Medical School, Vincent
Dr., Birmingham B15 2TT, UK. Phone: 44-121-4144078; Fax: 44-121-4143599; E-mail: p.j.l.lane@
bham.ac.uk
Received for publication 26 March 1998 and in revised form 1 May 1998.
References
1. Kumararatne, D.S. 1997. Tuberculosis and immunodeficiency—
of mice and men. Clin. Exp. Immunol. 107:11–14.
2. Toellner, K., S. Luther, D.M.-Y. Sze, R.K.-W. Choy, D.R.
Taylor, I.C.M. MacLennan, and H. Acha-Orbea. 1998. Th1
and Th2 characteristics start to develop during T cell priming
and are associated with an immediate ability to induce immu-
noglobulin class switching. J. Exp. Med. 187:1193–1201.
3. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cy-304 OX40 Ligand Upregulates Blr-1 and IL-4 in Naive CD4 T Cells
tokine with immunoregulatory functions that bridge innate
resistance and antigen-specific adaptive immunity. Annu.
Rev. Immunol. 13:251–276.
4. Cella, M., D. Scheidegger, K. Palmer-Lehman, P. Lane, A.
Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on den-
dritic cells triggers production of high levels of interleukin-12
and enhances T cell costimulatory capacity: T–T help via
APC activation. J. Exp. Med. 184:747–752.
5. Sousa, C.R., S. Hieny, T. Scharton-Kersten, D. Jankovic, H.
Charest, R.N. Germain, and A. Sher. 1997. In vivo micro-
bial stimulation induces rapid CD40 ligand–independent pro-
duction of interleukin 12 by dendritic cells and their redistri-
bution to T cell areas. J. Exp. Med. 186:1819–1829.
6. Szabo, S.J., A.S. Dighe, U. Gubler, and K.M. Murphy. 1997.
Regulation of the interleukin (IL)-12R beta 2 subunit ex-
pression in developing T helper 1 (Th1) and Th2 cells. J.
Exp. Med. 185:817–824.
7. Bendelac, A. 1995. Mouse NK11 T cells. Curr. Opin. Immu-
nol. 7:367–74.
8. von der Weid, T., A.M. Beebe, D.C. Roopenian, and R.L.
Coffman. 1996. Early production of IL-4 and induction of
Th2 responses in the lymph node originate from an MHC
class I-independent CD41NK1.12 T cell population. J. Im-
munol. 157:4421–4427.
9. Stockinger, B., T. Zal, A. Zal, and D. Gray. 1995. B cells so-
licit their own help from T cells. J. Exp. Med. 183:891–899.
10. Mason, D. 1996. The role of B cells in the programming of T
cells for IL-4 synthesis. J. Exp. Med. 183:717–719.
11. Stüber, E., and W. Strober. 1996. The T cell–B cell interac-
tion via OX40-OX40L is necessary for the cell-dependent
humoral immune response. J. Exp. Med. 183:979–989.
12. Gunn, M.D., V.N. Ngo, K.M. Ansel, E.H. Ekland, J.G. Cys-
ter, and L.T. Williams. 1998. A B-homing chemokine made
in lymphoid follicles activates Burkitt’s lymphoma type re-
ceptor-1. Nature. 391:799–802.
13. Traunecker, A., F. Oliveri, and K. Karjalainen. 1991. My-
eloma based expression system for production of large mam-
malian proteins. Trends Biotechnol. 9:109–113.
14. Calderhead, D.M., J.E. Buhlmann, A.J.M. Vandeneertwegh,
E. Claassen, R.J. Noelle, and H.P. Fell. 1993. Cloning of
mouse Ox40: a T cell activation marker that may mediate T-B
cell interactions. J. Immunol. 151:5261–5271.
15. Lane, P., W. Gerhard, S. Hubele, A. Lanzavecchia, and F.
McConnell. 1993. Expression and functional properties of
mouse B7/BB1 using a fusion protein between mouse CTLA4
and human g 1. Immunology. 80:56–61.
16. Svetic, A., F.D. Finkelman, Y.C. Jian, C.W. Dieffenbach,
D.E. Scott, K.F. McCarthy, A.D. Steinberg, and W.C.
Gause. 1991. Cytokine gene expression after in vivo primary
immunization with goat antibody to mouse IgD antibody. J.
Immunol. 147:2391–2397.
17. Forster, R., T. Emrich, E. Kremmer, and M. Lipp. 1994. Ex-
pression of the G-protein–coupled receptor BLR1 defines
mature, recirculating B cells and a subset of T-helper mem-
ory cells. Blood. 84:830–840.
18. Weibel, E.R. 1963. Principles and methods for the morpho-
metric study of the lung and other organs. Lab. Invest. 12:
131–155.
19. Luther, S.A., I. Maillard, F. Luthi, L. Scarpellino, H. Diggel-
mann, and H. Acha-Orbea. 1997. Early neutralizing antibody
response against mouse mammary tumor virus: critical role of
viral infection and superantigen-reactive T cells. J. Immunol.
159:2807–2814.
20. Stüber, E., M. Neurath, D. Calderhead, H.P. Fell, and W.
Strober. 1995. Cross-linking of OX40 ligand, a member of
the TNF/NGF cytokine family, induces proliferation and
differentiation in murine splenic B cells. Immunity. 2:507–521.
21. Austrup, F., D. Vestweber, E. Borges, M. Lohning, R.
Brauer, U. Herz, H. Renz, R. Hallmann, A. Scheffold, A.
Radbruch, and A. Hamann. 1997. P- and E-selectin mediate
recruitment of T-helper-1 but not T-helper-2 cells into in-
flamed tissues. Nature. 385:81–83.
22. Sallusto, F., C.R. Mackay, and A. Lanzavecchia. 1997. Selec-
tive expression of the eotaxin receptor CCR3 by human T
helper 2 cells. Science. 277:2005–2007.
23. Forster, R., A.E. Mattis, E. Kremmer, E. Wolf, G. Brem, and
M. Lipp. 1996. A putative chemokine receptor, BLR1, di-
rects B cell migration to defined lymphoid organs and specific
anatomic compartments of the spleen. Cell. 87:1037–1047.
24. Jacob, J., R. Kassir, and G. Kelsoe. 1991. In situ studies of the
primary immune response to (4-hydroxy-3-nitrophenyl)acetyl.
I. The architecture and dynamics of responding cell popula-
tions. J. Exp. Med. 173:1165–1175.
25. Liu, Y.J., J. Zhang, P.J. Lane, E.Y. Chan, and I.C. MacLen-
nan. 1991. Sites of specific B cell activation in primary and
secondary responses to T cell-dependent and T cell-indepen-
dent antigens. Eur. J. Immunol. 21:2951–2962.
26. Constant, S., C. Pfeiffer, A. Woodard, T. Pasqualini, and K.
Bottomly. 1995. Extent of T cell receptor ligation can deter-
mine the functional differentiation of naive CD41 T cells. J.
Exp. Med. 182:1591–1596.
27. Rincon, M., J. Anguita, T. Nakamura, E. Fikrig, and R.A.
Flavell. 1997. Interleukin (IL)-6 directs the differentiation of
IL-4–producing CD41 T cells. J. Exp. Med. 185:461–469.
28. Kopf, M., G. Legros, A.J. Coyle, M. Koscovilbois, and F.
Brombacher. 1995. Immune responses of IL-4, IL-5, IL-6
deficient mice. Immunol. Rev. 148:45–69.
29. Cyster, J.G., S.B. Hartley, and C.C. Goodnow. 1994. Com-
petition for follicular niches excludes self-reactive cells from
the recirculating B-cell repertoire. Nature. 371:389–395.
30. Ohshima, Y., Y. Tanaka, H. Tozawa, Y. Takahashi, C. Mal-
iszewski, and G. Delespesse. 1997. Expression and function
of OX40 ligand on human dendritic cells. J. Immunol. 159:
3838–3848.
31. Bonecchi, R., G. Bianchi, P.P. Bordignon, D. Dambrosio,
R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P.A. Gray, A.
Mantovani, and F. Sinigaglia. 1998. Differential expression of
chemokine receptors and chemotactic responsiveness of type
1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129–134.
32. Lens, S.M.A., R.L. Dejong, B. Hooibrink, B. Koopman,
S.T. Pals, M.H.J. Vanoers, and R.A.W. Vanlier. 1996. Phe-
notype and function of human B-cells expressing CD70
(CD27 ligand). Eur. J. Immunol. 26:2964–2971.
33. Hilkens, C.M.U., P. Kalinski, M. deBoer, and M.L. Kapsenberg.
1997. Human dendritic cells require exogenous interleukin-
12-inducing factors to direct the development of naive T-helper
cells toward the Th1 phenotype. Blood. 90:1920–1926.
34. Srikiatkhachorn, A., and T.J. Braciale. 1997. Virus-specific
CD81 T lymphocytes downregulate T helper cell type 2 cy-
tokine secretion and pulmonary eosinophilia during experi-
mental murine respiratory syncytial virus infection. J. Exp.
Med. 186:421–432.
35. Tascon, R.E., E. Stavropoulos, K.V. Lukacs, and M.J. Col-
ston. 1998. Protection against Mycobacterium tuberculosis infec-
tion by CD81 T cells requires the production of gamma in-
terferon. Infect. Immun. 66:830–834.